Clinical Medicine Research

Submit a Manuscript

Publishing with us to make your research visible to the widest possible audience.

Propose a Special Issue

Building a community of authors and readers to discuss the latest research and develop new ideas.

Mechanisms of Iron Deficiency in Obese Children

Obesity and iron deficiency are global public health problems. Obesity can cause nutritional disorders, such as iron deficiency. Obesity and iron deficiency during the rapid stages of growth and development in children can cause lasting and irreversible damage to the health of children and even into adulthood. Because the economy and living standards are improving, the incidence of childhood obesity increases yearly, at the same time, the incidence of iron deficiency in obese children is also higher. Obesity is closely related to the occurrence and development of iron deficiency, and the coexistence of the two can produce synergistic effects leading to serious harm, which is an urgent nutritional health problem in clinic. By impairing iron absorption, reducing iron excretion within cells, and by competing with the body for iron with the altered gut flora caused by obesity, obesity can disrupt the normal iron metabolism process and then lead to iron deficiency. The mechanism of obesity-associated iron deficiency is complex and may be related to inflammatory response, intestinal cells, anoxic microenvironment and intestinal flora. Therefore, in this review, we discuss possible mechanisms of obesity-associated iron deficiency to offer new methods and strategies for preventing and treating iron deficiency in obese children.

Obesity, Iron Deficiency, Anoxic Microenvironment, Inflammation, Gut Microbiota

Xin-yan Yan. (2023). Mechanisms of Iron Deficiency in Obese Children. Clinical Medicine Research, 12(5), 95-102.

Copyright © 2023 Authors retain the copyright of this article.
This article is an open access article distributed under the Creative Commons Attribution License ( which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

1. Ávila-Escalante ML, Coop-Gamas F, Cervantes-Rodríguez M, Méndez-Iturbide D, Aranda-González II. The effect of diet on oxidative stress and metabolic diseases-Clinically controlled trials. J Food Biochem. 2020; 44 (5): e13191. doi: 10.1111/jfbc.13191.
2. Crielaard BJ, Lammers T, Rivella S. Targeting iron metabolism in drug discovery and delivery. Nat Rev Drug Discov. 2017; 16 (6): 400-423. doi: 10.1038/nrd.2016.248.
3. Hentze MW, Muckenthaler MU, Galy B, Camaschella C. Two to tango: regulation of Mammalian iron metabolism. Cell. 2010; 142 (1): 24-38. doi: 10.1016/j.cell.2010.06.028.
4. Lozoff B, Georgieff MK. Iron deficiency and brain development. Semin Pediatr Neurol. 2006; 13 (3): 158-65. doi: 10.1016/j.spen.2006.08.004.
5. Chang S, Zeng L, Brouwer ID, Kok FJ, Yan H. Effect of iron deficiency anemia in pregnancy on child mental development in rural China. Pediatrics. 2013; 131 (3): e755-63. doi: 10.1542/peds.2011-3513.
6. Doom JR, Richards B, Caballero G, Delva J, Gahagan S, Lozoff B. Infant Iron Deficiency and Iron Supplementation Predict Adolescent Internalizing, Externalizing, and Social Problems. J Pediatr. 2018; 195: 199-205. e2. doi: 10.1016/j.jpeds.2017.12.008.
7. Marell PS, Blohowiak SE, Evans MD, Georgieff MK, Kling PJ, Tran PV. Cord Blood-Derived Exosomal CNTN2 and BDNF: Potential Molecular Markers for Brain Health of Neonates at Risk for Iron Deficiency. Nutrients. 2019; 11 (10): 2478. doi: 10.3390/nu11102478.
8. Sal E, Yenicesu I, Celik N, et al. Relationship between obesity and iron deficiency anemia: is there a role of hepcidin? Hematology. 2018; 23 (8): 542-548. doi: 10.1080/10245332.2018.1423671.
9. Menzie CM, Yanoff LB, Denkinger BI, et al. Obesity-related hypoferremia is not explained by differences in reported intake of heme and nonheme iron or intake of dietary factors that can affect iron absorption. J Am Diet Assoc. 2008; 108 (1): 145-8. doi: 10.1016/j.jada.2007.10.034.
10. World Health Organization—Obesity. Available online: on 26 november 2022).
11. World Health Organization—Obesity. Available online: (accessed on 26 November 2022).
12. World Health Organization—Health and wellbeing. Available online: on 26 november 2022).
13. Zhang Na, MA Guansheng. Interpretation of the Chinese Children Obesity Report. Chinese Journal of Nutrition. 2017; 39 (06): 530-534.
14. WENZEL BJ, STULTS HB, MAYER J. Hypoferraemia in obese adolescents. Lancet. 1962; 2 (7251): 327-8. doi: 10.1016/s0140-6736(62)90110-1.
15. Nead KG, Halterman JS, Kaczorowski JM, Auinger P, Weitzman M. Overweight children and adolescents: a risk group for iron deficiency. Pediatrics. 2004; 114 (1): 104-8. doi: 10.1542/peds.114.1.104.
16. Manios Y, Moschonis G, Chrousos GP, et al. The double burden of obesity and iron deficiency on children and adolescents in Greece: the Healthy Growth Study. J Hum Nutr Diet. 2013; 26 (5): 470-8. doi: 10.1111/jhn.12025.
17. Zheng H, Long W, Tan W, Yang C, Cao M, Zhu Y. Anaemia, iron deficiency, iron-deficiency anaemia and their associations with obesity among schoolchildren in Guangzhou, China. Public Health Nutr. 2020; 23 (10): 1693-1702. doi: 10.1017/S1368980019003604.
18. Zhu Y, He B, Xiao Y, Chen Y. Iron metabolism and its association with dyslipidemia risk in children and adolescents: a cross-sectional study. Lipids Health Dis. 2019; 18 (1): 50. doi: 10.1186/s12944-019-0985-8.
19. Zhang YX, Chen J, Liu XH. Profiles of anemia among school-aged children categorized by body mass index and waist circumference in Shandong, China. Pediatr Neonatol. 2021; 62 (2): 165-171. doi: 10.1016/j.pedneo.2020.11.002.
20. Sypes EE, Parkin PC, Birken CS, et al. Higher Body Mass Index Is Associated with Iron Deficiency in Children 1 to 3 Years of Age. J Pediatr. 2019; 207: 198-204. e1. doi: 10.1016/j.jpeds.2018.11.035.
21. González-Domínguez Á, Visiedo-García FM, Domínguez-Riscart J, González-Domínguez R, Mateos RM, Lechuga-Sancho AM. Iron Metabolism in Obesity and Metabolic Syndrome. Int J Mol Sci. 2020; 21 (15): 5529. doi: 10.3390/ijms21155529.
22. Ganz T. Macrophages and systemic iron homeostasis. J Innate Immun. 2012; 4 (5-6): 446-53. doi: 10.1159/000336423.
23. Katsarou A, Pantopoulos K. Basics and principles of cellular and systemic iron homeostasis. Mol Aspects Med. 2020; 75: 100866. doi: 10.1016/j.mam.2020.100866.
24. Gkouvatsos K, Papanikolaou G, Pantopoulos K. Regulation of iron transport and the role of transferrin. Biochim Biophys Acta. 2012; 1820 (3): 188-202. doi: 10.1016/j.bbagen.2011.10.013.
25. Sendamarai AK, Ohgami RS, Fleming MD, Lawrence CM. Structure of the membrane proximal oxidoreductase domain of human Steap3, the dominant ferrireductase of the erythroid transferrin cycle. Proc Natl Acad Sci U S A. 2008; 105 (21): 7410-5. doi: 10.1073/pnas.0801318105.
26. Shayeghi M, Latunde-Dada GO, Oakhill JS, et al. Identification of an intestinal heme transporter. Cell. 2005; 122 (5): 789-801. doi: 10.1016/j.cell.2005.06.025.
27. Schaer CA, Deuel JW, Bittermann AG, et al. Mechanisms of haptoglobin protection against hemoglobin peroxidation triggered endothelial damage. Cell Death Differ. 2013; 20 (11): 1569-79. doi: 10.1038/cdd.2013.113.
28. Chen C, Paw BH. Cellular and mitochondrial iron homeostasis in vertebrates. Biochim Biophys Acta. 2012; 1823 (9): 1459-67. doi: 10.1016/j.bbamcr.2012.01.003.
29. Hamdi A, Roshan TM, Kahawita TM, Mason AB, Sheftel AD, Ponka P. Erythroid cell mitochondria receive endosomal iron by a "kiss-and-run" mechanism. Biochim Biophys Acta. 2016; 1863 (12): 2859-2867. doi: 10.1016/j.bbamcr.2016.09.008.
30. Wang J, Pantopoulos K. Regulation of cellular iron metabolism. Biochem J. 2011; 434 (3): 365-81. doi: 10.1042/BJ20101825.
31. Ellulu MS, Patimah I, Khaza'ai H, Rahmat A, Abed Y. Obesity and inflammation: the linking mechanism and the complications. Arch Med Sci. 2017; 13 (4): 851-863. doi: 10.5114/aoms.2016.58928.
32. Osbak PS, Bindslev N, Hansen MB. Relationships between body mass index and short-circuit current in human duodenal and colonic mucosal biopsies. Acta Physiol (Oxf). 2011; 201 (1): 47-53. doi: 10.1111/j.1748-1716.2010.02202.x.
33. Anvari G, Bellas E. Hypoxia induces stress fiber formation in adipocytes in the early stage of obesity. Sci Rep. 2021; 11 (1): 21473. doi: 10.1038/s41598-021-00335-1.
34. Das NK, Schwartz AJ, Barthel G, et al. Microbial Metabolite Signaling Is Required for Systemic Iron Homeostasis. Cell Metab. 2020; 31 (1): 115-130. e6. doi: 10.1016/j.cmet.2019.10.005.
35. Mărginean CO, Meliţ LE, Huțanu A, Ghiga DV, Săsăran MO. The adipokines and inflammatory status in the era of pediatric obesity. Cytokine. 2020; 126: 154925. doi: 10.1016/j.cyto.2019.154925.
36. Mărginean CO, Meliţ LE, Ghiga DV, Mărginean MO. Early Inflammatory Status Related to Pediatric Obesity. Front Pediatr. 2019; 7: 241. doi: 10.3389/fped.2019.00241.
37. Mena NP, Esparza A, Tapia V, Valdés P, Núñez MT. Hepcidin inhibits apical iron uptake in intestinal cells. Am J Physiol Gastrointest Liver Physiol. 2008; 294 (1): G192-8. doi: 10.1152/ajpgi.00122.2007.
38. Ambachew S, Biadgo B. Hepcidin in Iron Homeostasis: Diagnostic and Therapeutic Implications in Type 2 Diabetes Mellitus Patients. Acta Haematol. 2017; 138 (4): 183-193. doi: 10.1159/000481391.
39. Bekri S, Gual P, Anty R, et al. Increased adipose tissue expression of hepcidin in severe obesity is independent from diabetes and NASH. Gastroenterology. 2006; 131 (3): 788-96. doi: 10.1053/j.gastro.2006.07.007.
40. Ganz T, Nemeth E. Hepcidin and iron homeostasis. Biochim Biophys Acta. 2012; 1823 (9): 1434-43. doi: 10.1016/j.bbamcr.2012.01.014.
41. Wrighting DM, Andrews NC. Interleukin-6 induces hepcidin expression through STAT3. Blood. 2006; 108 (9): 3204-9. doi: 10.1182/blood-2006-06-027631.
42. Chaston T, Chung B, Mascarenhas M, et al. Evidence for differential effects of hepcidin in macrophages and intestinal epithelial cells. Gut. 2008; 57 (3): 374-82. doi: 10.1136/gut.2007.131722.
43. Nemeth E, Rivera S, Gabayan V, et al. IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin. J Clin Invest. 2004; 113 (9): 1271-6. doi: 10.1172/JCI20945.
44. Sonnweber T, Ress C, Nairz M, et al. High-fat diet causes iron deficiency via hepcidin-independent reduction of duodenal iron absorption. J Nutr Biochem. 2012; 23 (12): 1600-8. doi: 10.1016/j.jnutbio.2011.10.013.
45. Mishra J, Simonsen R, Kumar N. Intestinal breast cancer resistance protein (BCRP) requires Janus kinase 3 activity for drug efflux and barrier functions in obesity. J Biol Chem. 2019; 294 (48): 18337-18348. doi: 10.1074/jbc.RA119.007758.
46. Fillebeen C, Charlebois E, Wagner J, et al. Transferrin receptor 1 controls systemic iron homeostasis by fine-tuning hepcidin expression to hepatocellular iron load. Blood. 2019; 133 (4): 344-355. doi: 10.1182/blood-2018-05-850404.
47. Roe MA, Collings R, Dainty JR, Swinkels DW, Fairweather-Tait SJ. Plasma hepcidin concentrations significantly predict interindividual variation in iron absorption in healthy men. Am J Clin Nutr. 2009; 89 (4): 1088-91. doi: 10.3945/ajcn.2008.27297.
48. Ganz T, Nemeth E. Iron imports. IV. Hepcidin and regulation of body iron metabolism. Am J Physiol Gastrointest Liver Physiol. 2006; 290 (2): G199-203. doi: 10.1152/ajpgi.00412.2005.
49. Zhang Z, Funcke JB, Zi Z, et al. Adipocyte iron levels impinge on a fat-gut crosstalk to regulate intestinal lipid absorption and mediate protection from obesity. Cell Metab. 2021; 33 (8): 1624-1639.e9. doi: 10.1016/j.cmet.2021.06.001.
50. Shah YM, Matsubara T, Ito S, Yim SH, Gonzalez FJ. Intestinal hypoxia-inducible transcription factors are essential for iron absorption following iron deficiency. Cell Metab. 2009; 9 (2): 152-64. doi: 10.1016/j.cmet.2008.12.012.
51. Muckenthaler MU, Galy B, Hentze MW. Systemic iron homeostasis and the iron-responsive element/iron-regulatory protein (IRE/IRP) regulatory network. Annu Rev Nutr. 2008; 28: 197-213. doi: 10.1146/annurev.nutr.28.061807.155521.
52. Luo QQ, Wang D, Yu MY, Zhu L. Effect of hypoxia on the expression of iron regulatory proteins 1 and the mechanisms involved. IUBMB Life. 2011; 63 (2): 120-8. doi: 10.1002/iub.419.
53. Pereira MA, Kartashov AI, Ebbeling CB, et al. Fast-food habits, weight gain, and insulin resistance (the CARDIA study): 15-year prospective analysis. Lancet. 2005; 365 (9453): 36-42. doi: 10.1016/S0140-6736(04)17663-0.
54. Bäckhed F, Ding H, Wang T, et al. The gut microbiota as an environmental factor that regulates fat storage. Proc Natl Acad Sci U S A. 2004; 101 (44): 15718-23. doi: 10.1073/pnas.0407076101.
55. Ridaura VK, Faith JJ, Rey FE, et al. Gut microbiota from twins discordant for obesity modulate metabolism in mice. Science. 2013; 341 (6150): 1241214. doi: 10.1126/science.1241214.
56. Yoo W, Zieba JK, Foegeding NJ, et al. High-fat diet-induced colonocyte dysfunction escalates microbiota-derived trimethylamine N-oxide. Science. 2021; 373 (6556): 813-818. doi: 10.1126/science.aba3683.
57. Ley RE, Bäckhed F, Turnbaugh P, Lozupone CA, Knight RD, Gordon JI. Obesity alters gut microbial ecology. Proc Natl Acad Sci U S A. 2005; 102 (31): 11070-5. doi: 10.1073/pnas.0504978102.
58. Zhang C, Zhang M, Pang X, Zhao Y, Wang L, Zhao L. Structural resilience of the gut microbiota in adult mice under high-fat dietary perturbations. ISME J. 2012; 6 (10): 1848-57. doi: 10.1038/ismej.2012.27.
59. Canfora EE, Meex RCR, Venema K, Blaak EE. Gut microbial metabolites in obesity, NAFLD and T2DM. Nat Rev Endocrinol. 2019; 15 (5): 261-273. doi: 10.1038/s41574-019-0156-z.
60. Zhang D, Gao X, Li H, et al. The microbiota regulates hematopoietic stem cell fate decisions by controlling iron availability in bone marrow. Cell Stem Cell. 2022; 29 (2): 232-247.e7. doi: 10.1016/j.stem.2021.12.009.
61. Van Immerseel F, De Buck J, Pasmans F, et al. Invasion of Salmonella enteritidis in avian intestinal epithelial cells in vitro is influenced by short-chain fatty acids. Int J Food Microbiol. 2003; 85 (3): 237-48. doi: 10.1016/s0168-1605(02)00542-1.
62. Garcia-Mantrana I, Selma-Royo M, Alcantara C, Collado MC. Shifts on Gut Microbiota Associated to Mediterranean Diet Adherence and Specific Dietary Intakes on General Adult Population. Front Microbiol. 2018; 9: 890. doi: 10.3389/fmicb.2018.00890.
63. Rogero MM, Calder PC. Obesity, Inflammation, Toll-Like Receptor 4 and Fatty Acids. Nutrients. 2018; 10 (4): 432. doi: 10.3390/nu10040432.
64. Gotfried J, Naftali T, Schey R. Role of Cannabis and Its Derivatives in Gastrointestinal and Hepatic Disease. Gastroenterology. 2020; 159 (1): 62-80. doi: 10.1053/j.gastro.2020.03.087.
65. Bessman NJ, Mathieu JRR, Renassia C, et al. Dendritic cell-derived hepcidin sequesters iron from the microbiota to promote mucosal healing. Science. 2020; 368 (6487): 186-189. doi: 10.1126/science.aau6481.
66. Asadzadeh Manjili F, Yousefi-Ahmadipour A, Kazemi Arababadi M. The roles played by TLR4 in the pathogenesis of multiple sclerosis; A systematic review article. Immunol Lett. 2020; 220: 63-70. doi: 10.1016/j.imlet.2020.02.004.
67. Ono-Moore KD, Zhao L, Huang S, et al. Transgenic mice with ectopic expression of constitutively active TLR4 in adipose tissues do not show impaired insulin sensitivity. Immun Inflamm Dis. 2017; 5 (4): 526-540. doi: 10.1002/iid3.162.